In an 8-K filing released after the close, Tilray (NASDAQ: TLRY) announced that Cowen and Company has been selected to sell up to $400 million in stock once an S-3 registration statement is effective. Any sales will be an “at-the-market offering”: Pursuant to the Sales Agreement, each time Tilray wishes to issue and sell Shares under
[Read More ...]
Originally posted on Tilray Taps Cowen and Company to Sell up to $400 Million in Stock via Vic Neufeld Medical Marijuana News
No comments:
Post a Comment